ARCHIVES

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

House Democrats Take More Swings At Tobacco Industry

February 17, 1989

In Brief: NCI Awards 4 Contracts For Enrichment Program; Dana-Farber Names Breast Center Leadership

July 10, 1992

Senate Investigates Opioid Manufacturers, Requests Study of Impact of DEA Policies

May 11, 2012

NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups.

January 12, 2007

NCI Cooperative Group Clinical Trials Approved

February 26, 2010

NCI-Approved CTEP Trials For the Month of November

November 30, 2012